Grief is the most natural human response to loss, and each individual’s experience with it is unique.
As more and more Australians are using antidepressants, or medications associated with mental illness, the time is right for a re-think on the approach to treatment of these conditions.
Understanding an individual’s genetics can help doctors to more accurately determine which drug and which dose is best for a patient.
The potential for precision medicine to improve care and speed the development of new treatments has only just begun to be tapped.
myDNA, in collaboration with Melbourne Health, has pioneered a pharmacogenomic decision support tool that links a patient’s DNA results with known drug metabolic profiles